These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2658726)

  • 1. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
    Schlebusch H; Jarausch J; Domke I
    Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay.
    Ray JE; Crisan D; Howrie DL
    Clin Chem; 1991 Jan; 37(1):94-8. PubMed ID: 1988216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
    Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
    Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
    Graves SW; Sharma K; Chandler AB
    Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
    Graves SW; Lincoln K; Cook SL; Seely EW
    Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
    Qazzaz HM; Goudy S; Miller JJ; Valdes R
    Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
    Embree L; McErlane KM
    Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors.
    Datta P; Hinz V; Klee G
    Clin Biochem; 1996 Dec; 29(6):541-7. PubMed ID: 8939401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
    Datta P; Dasgupta A
    Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
    Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
    Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.